Terry Budge
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
Terry Budge
Non-Executive Director / Argenica Therapeutics
Terry Budge has over 30 years of experience in the Australian banking industry.
He was managing director of BankWest from December 1997 to May 2004 where he guided the bank through a period of significant growth culminating in the sale of the minority shareholdings to parent company HBOS in September 2003. Mr Budge had previously worked at National Australia Bank for 25 years in a number of senior executive roles including as state manager of Queensland, state manager of NSW & ACT, general manager of group strategic development, and as chief economist.
Mr Budge holds a Bachelor of Economics from Monash University, is a graduate of the Advanced Management Program from Harvard Business School, a graduate and Fellow of the Australian Institute of Company Directors, a Fellow of the Australian Institute of Banking and Finance, and a Fellow of the Australian Institute of Management.
He was managing director of BankWest from December 1997 to May 2004 where he guided the bank through a period of significant growth culminating in the sale of the minority shareholdings to parent company HBOS in September 2003. Mr Budge had previously worked at National Australia Bank for 25 years in a number of senior executive roles including as state manager of Queensland, state manager of NSW & ACT, general manager of group strategic development, and as chief economist.
Mr Budge holds a Bachelor of Economics from Monash University, is a graduate of the Advanced Management Program from Harvard Business School, a graduate and Fellow of the Australian Institute of Company Directors, a Fellow of the Australian Institute of Banking and Finance, and a Fellow of the Australian Institute of Management.
Lists and Charts
Roles
Year started and most recent title
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 72nd |  | Westoz Investment Company | $24.7m |
| 74th | | Structural Monitoring Systems | $22.6m |
| 75th |  | Orbital Corporation | $22.5m |
| 77th |  | Hiremii | $21.1m |
| 78th | | Pentanet | $20.9m |
201 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| NEW ROLE: Non-Executive Director, Argenica Therapeutics | 10 Aug 2021 |
| REMUNERATION UPDATE: Non-Executive Director, Westoz Investment Company | 30 Jun 2020 |
